VeriMomSollte ich trifluoropropyl cyclotrisiloxane in der Schwangerschaft meiden? | VeriMom
No EU harmonised CLP (Annex VI) or Annex II/III cosmetic restriction found; supplier safety data sheets list H361 (suspected of damaging fertility or the unborn child) as a notified/self-classification, but no harmonised H360/H361 CLH entry was located on ECHA. No peer‑reviewed reproductive/developmental studies on this specific CAS (2374‑14‑3) were found in PubMed. (ECHA substance page; supplier SDS; PubChem).
ECHA regulatory hazard statements
- •H361
- •H361F
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Ist trifluoropropyl cyclotrisiloxane in der Schwangerschaft sicher?
- No EU harmonised CLP (Annex VI) or Annex II/III cosmetic restriction found; supplier safety data sheets list H361 (suspected of damaging fertility or the unborn child) as a notified/self-classification, but no harmonised H360/H361 CLH entry was located on ECHA. No peer‑reviewed reproductive/developmental studies on this specific CAS (2374‑14‑3) were found in PubMed. (ECHA substance page; supplier SDS; PubChem).
- Ist trifluoropropyl cyclotrisiloxane während des Stillens sicher?
- Same weight of evidence as pregnancy: no harmonised CMR classification or authoritative cosmetic-safety opinion (SCCS/CIR) found; some suppliers/SDSs notify reproductive hazard H361 but this appears to be company/self‑classification rather than a harmonised EU CLH. No specific data on transfer to breastmilk for this substance in the literature. (ECHA; supplier SDS).
- Ist trifluoropropyl cyclotrisiloxane sicher für Babyhaut?
- Hazard evidence mirrors adult (no harmonised CLH; supplier self‑notifications of H361 only). Dermal exposure potential is low-to-measurable for cyclic siloxanes used topically, so exposure for infants is increased because of immature barrier and higher surface‑area‑to‑weight; per your scoring rules adult exposure scored as low (1) and infant exposure increased by +1. No infant-specific toxicokinetic or dermal absorption studies for CAS 2374‑14‑3 were found. (PubChem; supplier SDS; ECHA dossier).
- Wie bewertet VeriMom trifluoropropyl cyclotrisiloxane?
- VeriMom bewertet trifluoropropyl cyclotrisiloxane mit 33/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu trifluoropropyl cyclotrisiloxane?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu trifluoropropyl cyclotrisiloxane basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.